Belite Bio Inc ADR
Price & Volume
Stats
See moreOpen | $153.94 |
Previous Close | $151.72 |
Day Range | $151.73-$155.56 |
52W Range | $62.18-$200 |
Market Cap | $6.1B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.64 |
News
See moreYahoo Finance • 18 days ago
Belite Bio outlines February 12, 2027 PDUFA date for Tinlarebant in Stargardt disease following FDA priority review acceptance
Yahoo Finance • 3 months ago
After-Hours Earnings Report for May 20, 2026 : NVDA, INTU, NDSN, ENS, URBN, BLTE, STEP, ELF, SBLK, CSAI
Yahoo Finance • 4 months ago
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026
Yahoo Finance • 6 months ago
Belite Bio price target raised to $266 from $200 at Cantor Fitzgerald
About
CEO | Dr. Yu-Hsin Lin M.B.A., Ph.D. |
CFO | Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A. |
Address | 12750 High Bluff Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 41 |